TJ Martell Foundation
-
Gene network for leukemia factor
A new method speeds the analysis of factors that control gene expression from days to minutes, allowing researchers to uncover new targets for cancer treatment. Read MoreFeb 4, 2021
-
Pancreatic cancer development
Elevated levels of the factor G-CSF appear to promote the development of aggressive pancreatic cancer, suggesting a new therapeutic approach for this devastating disease. Read MoreAug 31, 2017
-
HDAC3 role in B-cell development
The histone deacetylase HDAC3 is required for the maturation of B cells, white blood cells that produce antibodies. Read MoreAug 3, 2017
-
VICC racers compete in downtown bed race for cancer research funding
Participating in the Downtown Derby Bed Race to benefit the T.J. Martell Foundation are, from left, Ross Oreto, Lauren Hackett, Li Wen, Clay Washburn and Tommy Hollinden. (photo by Sarah Como) Staff members from Vanderbilt-Ingram Cancer Center (VICC) garnered an impressive second place finish in last month’s Downtown Derby Bed… Read MoreJun 15, 2017
-
Vanderbilt mourns loss of philanthropist Tony Martell
Members of the Vanderbilt community are mourning the loss of music executive and health care philanthropist Tony Martell, who died Sunday, Nov. 27, at his home in New Jersey. He was 90. Read MoreDec 7, 2016
-
Fashion show to benefit VICC ovarian cancer research
Fall fashions for women will be on display during the 4th Annual Chic Awearness Fashion Show promoting ovarian cancer awareness and research. The event, to be held Monday, Sept. 26, 6:30 to 8:30 p.m., will benefit the T.J. Martell Foundation, which supports ovarian cancer research at Vanderbilt-Ingram Cancer Center (VICC). Read MoreSep 15, 2016
-
Study suggests cancer’s ‘clock’ can be rewound
Researchers at Vanderbilt University Medical Center have “turned back the clock” in a mouse model of metaplasia — precancerous stomach lesions — raising hopes that gastric cancer, a worldwide scourge that’s rising in the United States, can be prevented. Read MoreMar 17, 2016
-
T.J. Martell Foundation lauds Pietenpol’s research
Jennifer Pietenpol, Ph.D., B.F. Byrd Jr. Professor of Oncology and director of Vanderbilt-Ingram Cancer Center (VICC), was honored with the Medical Research Advancement Award during the 8th Annual T.J. Martell Foundation Nashville Honors Gala held recently at the Omni Nashville Hotel. Read MoreMar 17, 2016
-
New lead for ovarian cancer treatment
Combining inhibitors of the BMP signaling pathway with standard chemotherapy drugs may overcome drug resistance in ovarian cancer. Read MoreDec 10, 2015
-
Growth factor blockade targets breast tumors
Inhibition of BMP growth factor signaling reduces breast tumor burden and metastasis. Read MoreAug 14, 2014
-
Photo: Sarcoma research support
The FTL Sarcoma Fund, in partnership with the T.J. Martell Foundation, recently presented a gift to the Vanderbilt-Ingram Cancer Center in support of sarcoma research in memory of Warner Music Nashville colleague Lindsay Walleman. Read MoreApr 10, 2014
-
T.J. Martell Foundation lauds Hiebert’s research
Scott Hiebert, Ph.D., associate director of Basic Research at Vanderbilt-Ingram Cancer Center (VICC), was celebrated for his contributions to cancer research during the 6th Annual Nashville Honors Gala benefiting the T.J. Martell Foundation. Read MoreMar 20, 2014
-
McBride’s fans band together to support cancer research efforts
On Tuesday, award-winning country music star Martina McBride and a group of her fans presented a check for $40,550 in support of cancer research at Vanderbilt-Ingram Cancer Center. Read MoreJun 6, 2013
-
Disney TV star to headline event to raise funds for cancer research
Disney television personality Coco Jones will be the featured performer at this year’s Dunkin’ Donuts/Baskin-Robbins Family Day in Nashville. The annual T.J. Martell Foundation event, which raises funds in support of cancer research at institutions like Vanderbilt-Ingram Cancer Center, will be held Sunday, Nov. 11, from 1 to 4 p.m. at the Curb Event Center, Belmont University. Read MoreNov 8, 2012
-
New drug mutes more melanomas
An experimental melanoma drug may be beneficial for patients not eligible for targeted therapies. Read MoreApr 26, 2012